Samsung Electronics Increases Investment in U.S. Genomics Firm with $175 Million, Becoming Largest Shareholder

Deep News08:10

Samsung Electronics announced on Wednesday that it will participate in an expanded Series E funding round for the U.S. genomics technology company Element Biosciences, investing an additional $175 million to become its largest shareholder.

In a press release, Samsung Electronics Co., Ltd. stated that this investment represents a further strategic commitment, following its participation in Element Biosciences' Series D funding round in July 2024.

Element Biosciences, headquartered in San Diego, California, is focused on developing next-generation DNA sequencing and multi-omics platforms for biomedical research, drug development, clinical studies, agriculture, and other life science fields.

Samsung Electronics Co., Ltd. indicated that this investment aligns with its strategic objective of expanding its business into the precision medicine and digital health technology sectors.

Tae-moon Roh, co-CEO of Samsung's mobile business, said in a statement: "The combination of Samsung Electronics' expertise in AI, medical devices, and digital health with Element's innovative genomic analysis technology holds the potential for synergistic effects that will help shape the future of personalized medicine."

Samsung emphasized that Element's next-generation gene sequencing technology and multi-omics capabilities are key areas of focus.

Multi-omics is a technology that enables the simultaneous analysis of various types of biological data, including not only DNA but also RNA and proteins, providing a more comprehensive understanding of how genetic information functions within an organism.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159133892?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 08:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159133892","market":"us","top_or_hot":-1,"title":"Samsung Electronics Increases Investment in U.S. Genomics Firm with $175 Million, Becoming Largest Shareholder","media":"Deep News","content":"<p>Samsung Electronics announced on Wednesday that it will participate in an expanded Series E funding round for the U.S. genomics technology company Element Biosciences, investing an additional $175 million to become its largest shareholder.<br><br>In a press release, <b>Samsung Electronics Co., Ltd.</b> stated that this investment represents a further strategic commitment, following its participation in Element Biosciences' Series D funding round in July 2024.<br><br>Element Biosciences, headquartered in San Diego, California, is focused on developing next-generation DNA sequencing and multi-omics platforms for biomedical research, drug development, clinical studies, agriculture, and other life science fields.<br><br><b>Samsung Electronics Co., Ltd.</b> indicated that this investment aligns with its strategic objective of expanding its business into the precision medicine and digital health technology sectors.<br><br>Tae-moon Roh, co-CEO of Samsung's mobile business, said in a statement: \"The combination of Samsung Electronics' expertise in AI, medical devices, and digital health with Element's innovative genomic analysis technology holds the potential for synergistic effects that will help shape the future of personalized medicine.\"<br><br>Samsung emphasized that Element's next-generation gene sequencing technology and multi-omics capabilities are key areas of focus.<br><br>Multi-omics is a technology that enables the simultaneous analysis of various types of biological data, including not only DNA but also RNA and proteins, providing a more comprehensive understanding of how genetic information functions within an organism.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Samsung Electronics Increases Investment in U.S. Genomics Firm with $175 Million, Becoming Largest Shareholder</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSamsung Electronics Increases Investment in U.S. Genomics Firm with $175 Million, Becoming Largest Shareholder\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-06-10 08:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Samsung Electronics announced on Wednesday that it will participate in an expanded Series E funding round for the U.S. genomics technology company Element Biosciences, investing an additional $175 million to become its largest shareholder.<br><br>In a press release, <b>Samsung Electronics Co., Ltd.</b> stated that this investment represents a further strategic commitment, following its participation in Element Biosciences' Series D funding round in July 2024.<br><br>Element Biosciences, headquartered in San Diego, California, is focused on developing next-generation DNA sequencing and multi-omics platforms for biomedical research, drug development, clinical studies, agriculture, and other life science fields.<br><br><b>Samsung Electronics Co., Ltd.</b> indicated that this investment aligns with its strategic objective of expanding its business into the precision medicine and digital health technology sectors.<br><br>Tae-moon Roh, co-CEO of Samsung's mobile business, said in a statement: \"The combination of Samsung Electronics' expertise in AI, medical devices, and digital health with Element's innovative genomic analysis technology holds the potential for synergistic effects that will help shape the future of personalized medicine.\"<br><br>Samsung emphasized that Element's next-generation gene sequencing technology and multi-omics capabilities are key areas of focus.<br><br>Multi-omics is a technology that enables the simultaneous analysis of various types of biological data, including not only DNA but also RNA and proteins, providing a more comprehensive understanding of how genetic information functions within an organism.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4170","symbol_name":"电脑硬件、储存设备及电脑周边","start_time":0,"source_url":"","article_id":"1159133892","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159133892","pubTimestamp":1781050245,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Samsung Electronics announced on Wednesday that it will participate in an expanded Series E funding round for the U.S. genomics technology company Element Biosciences, investing an additional $175...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4170":"电脑硬件、储存设备及电脑周边","BK4543":"AI","EDZ":"新兴市场ETF-Direxion三倍做空","BK4504":"桥水持仓","IEMG":"iShares Core MSCI Emerging Markets ETF","EEMO":"Invesco S&P Emerging Markets Momentum ETF","SSNLF":"三星电子","BK4550":"红杉资本持仓","BK4588":"碎股","WTAI":"WisdomTree Artificial Intelligence and Innovation Fund","BK4585":"ETF&股票定投概念","DRAM":"Roundhill Memory ETF","BK4581":"高盛持仓"},"translate_title":"三星电子1.75亿美元增资美基因组学公司成最大股东","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/b9048a93ace5af2cedc0ae49696846f0","symbols_score_info":{"EEMO":1,"IEMG":1,"EDZ":1,"DRAM":1,"SSNLF":1,"WTAI":1},"content_text":"Samsung Electronics announced on Wednesday that it will participate in an expanded Series E funding round for the U.S. genomics technology company Element Biosciences, investing an additional $175 million to become its largest shareholder.In a press release, Samsung Electronics Co., Ltd. stated that this investment represents a further strategic commitment, following its participation in Element Biosciences' Series D funding round in July 2024.Element Biosciences, headquartered in San Diego, California, is focused on developing next-generation DNA sequencing and multi-omics platforms for biomedical research, drug development, clinical studies, agriculture, and other life science fields.Samsung Electronics Co., Ltd. indicated that this investment aligns with its strategic objective of expanding its business into the precision medicine and digital health technology sectors.Tae-moon Roh, co-CEO of Samsung's mobile business, said in a statement: \"The combination of Samsung Electronics' expertise in AI, medical devices, and digital health with Element's innovative genomic analysis technology holds the potential for synergistic effects that will help shape the future of personalized medicine.\"Samsung emphasized that Element's next-generation gene sequencing technology and multi-omics capabilities are key areas of focus.Multi-omics is a technology that enables the simultaneous analysis of various types of biological data, including not only DNA but also RNA and proteins, providing a more comprehensive understanding of how genetic information functions within an organism.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159133892","isCrawlerRequest":true}